J. Goldman & Co’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Sell |
52,384
-27,003
| -34% | -$73.2K | ﹤0.01% | 301 |
|
|
2025
Q1 | $179K | Hold |
79,387
| – | – | ﹤0.01% | 289 |
|
|
2024
Q4 | $278K | Sell |
79,387
-175,503
| -69% | -$614K | 0.01% | 286 |
|
|
2024
Q3 | $1.05M | Buy |
254,890
+27,000
| +12% | +$111K | 0.03% | 201 |
|
|
2024
Q2 | $820K | Sell |
227,890
-50,698
| -18% | -$183K | 0.02% | 218 |
|
|
2024
Q1 | $919K | Buy |
278,588
+116,588
| +72% | +$385K | 0.03% | 189 |
|
|
2023
Q4 | $374K | Sell |
162,000
-283,485
| -64% | -$655K | 0.02% | 177 |
|
|
2023
Q3 | $575K | Buy |
445,485
+94,500
| +27% | +$122K | 0.02% | 172 |
|
|
2023
Q2 | $463K | Sell |
350,985
-256,515
| -42% | -$339K | 0.02% | 194 |
|
|
2023
Q1 | $429K | Buy |
607,500
+297,000
| +96% | +$210K | 0.02% | 190 |
|
|
2022
Q4 | $233K | Hold |
310,500
| – | – | 0.01% | 228 |
|
|
2022
Q3 | $267K | Buy |
310,500
+175,500
| +130% | +$151K | 0.01% | 230 |
|
|
2022
Q2 | $151K | Sell |
135,000
-82,051
| -38% | -$91.8K | 0.01% | 220 |
|
|
2022
Q1 | $243K | Buy |
217,051
+149,550
| +222% | +$167K | 0.01% | 227 |
|
|
2021
Q4 | $108K | Sell |
67,501
-173,912
| -72% | -$278K | 0.01% | 237 |
|
|
2021
Q3 | $584K | Sell |
241,413
-385,008
| -61% | -$931K | 0.03% | 202 |
|
|
2021
Q2 | $1.99M | Buy |
626,421
+563,654
| +898% | +$1.79M | 0.08% | 175 |
|
|
2021
Q1 | $212K | Sell |
62,767
-397,284
| -86% | -$1.34M | 0.01% | 305 |
|
|
2020
Q4 | $1.65M | Buy |
460,051
+16,534
| +4% | +$59.2K | 0.08% | 163 |
|
|
2020
Q3 | $1.16M | Buy |
+443,517
| New | +$1.16M | 0.08% | 149 |
|